This site is intended for UK healthcare professionals

This non-promotional podcast has been developed and funded by Pfizer Ltd. and is intended for UK healthcare professionals only.

ATTR‑CM Series – Episode 1: Understanding Cardiac Amyloidosis

Dr Kate Gatenby provides an overview of cardiac amyloidosis, different types of cardiac amyloidosis and clinical red flags for ATTR-CM.

Share this episode:

Speaker

Dr Kate Gatenby, Cardiology Consultant, Leeds General Infirmary, UK

For more expert-led non-promotional content on heart failure, cardiac amyloidosis and ATTR-CM and other podcasts in the series, please visit the Pfizer Medical website. Clicking this link will redirect you to the Pfizer Medical website, a non-promotional website developed and funded by Pfizer Ltd. for UK healthcare professionals.

Abbreviation:
ATTR-CM: Transthyretin amyloid cardiomyopathy.

PP-UNP-GBR-14085 | March 2026

To continue, please confirm that you are a healthcare professional in the United Kingdom.